Funding Agreements in the Biotechnology Industry

143 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Johnson & Johnson Innovation LLC and Decoy Therapeutics Inc. QuickFire Challenge Award Agreement
Funding Agreements
Flex Pharma, Inc.
Biotechnology
2025
Johnson & Johnson Innovation LLC and Decoy Therapeutics, Inc. QuickFire Challenge Grant Agreement
Funding Agreements
Flex Pharma, Inc.
Biotechnology
2025
Johnson & Johnson Innovation LLC and Decoy Therapeutics Inc. Blue Knight Resident QuickFire Challenge Award Agreement
Funding Agreements
Flex Pharma, Inc.
Biotechnology
2025
Amendment No. 1 to Grant Agreement between Bill & Melinda Gates Foundation and Decoy Therapeutics, Inc.
Funding Agreements
Flex Pharma, Inc.
Biotechnology
2025
Grant Agreement between Bill & Melinda Gates Foundation and Decoy Therapeutics, Inc. for Antiviral Technology Development
Funding Agreements
Flex Pharma, Inc.
Biotechnology
2025
Clinical Trial Funding Agreement between TuHURA Biosciences, Inc. and Kineta, Inc. dated December 11, 2024
Funding Agreements
PROTEOSTASIS THERAPEUTICS, INC.
Biotechnology
DE
2024
Grant Agreement Between Dyadic International Inc. and Bill & Melinda Gates Foundation for Monoclonal Antibody Production
Funding Agreements
DYADIC INTERNATIONAL INC
Biotechnology
2024
Clinical Trial Funding Agreement between Double Point Ventures LLC and Lumos Pharma, Inc. (October 22, 2024)
Funding Agreements
NEWLINK GENETICS CORP
Biotechnology
DE
2024
RRPV Project Award Agreement between Advanced Technology International and GeoVax, Inc. for Phase 2b COVID-19 Vaccine Study
Funding Agreements
GeoVax Labs, Inc.
Biotechnology
2024
Cost Reimbursement Subaward Agreement between The Trustees of Columbia University and Clene Nanomedicine Inc. for NIH-Funded ALS Research
Funding Agreements
Chelsea Worldwide Inc.
Biotechnology
2024
Funding Agreement for ChAdOx1 MERS Vaccine Development among University of Oxford, Barinthus Biotherapeutics (UK) Limited, and CEPI
Funding Agreements
Vaccitech plc
Biotechnology
2024
Amendment No. 2 to Development Funding and Royalties Agreement between Ligand Pharmaceuticals, Inc. and Palvella Therapeutics, Inc.
Funding Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2024
Strategic Innovation Fund Contribution Agreement between His Majesty the King in Right of Canada and Edesa Biotech Research, Inc. (with Edesa Biotech, Inc. as Guarantor)
Funding Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2023
Amendment Letter to Credit Agreement among Elutia Inc., SWK Funding LLC, and Lenders (November 2023)
Funding Agreements
AZIYO BIOLOGICS, INC.
Biotechnology
2023
Amendment No. 4 to Development Program Letter Agreement between Arcturus Therapeutics, Inc. and Cystic Fibrosis Foundation
Funding Agreements
Arcturus Therapeutics Holdings Inc.
Biotechnology
2023
Amendment No. P00001 to OTAR Agreement No. 75A50122C00081 Between Vir Biotechnology, Inc. and HHS/BARDA
Funding Agreements
Vir Biotechnology, Inc.
Biotechnology
2023
SynergiQc Network and Research Funding Agreement among NRC, Inspirevax Inc., Oragenics Inc., and CQDM
Funding Agreements
ORAGENICS INC
Biotechnology
2023
Bridge Funding Agreement between Aceragen, Inc. and NovaQuest Co-Investment Fund XV, L.P. (July 11, 2023)
Funding Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
NY
2023
Amended and Restated Research Funding Agreement between Stanislaw R. Burzynski and Burzynski Research Institute, Inc.
Funding Agreements
BURZYNSKI RESEARCH INSTITUTE INC
Biotechnology
2023
Funding Agreement between The Wellcome Trust Limited and PTC Therapeutics, Inc. for Research on Bmi-1 Expression in Tumor Stem Cells
Funding Agreements
PTC THERAPEUTICS, INC.
Biotechnology
DE
2023
Unrestricted Grant Agreement between AIM ImmunoTech Inc. and Erasmus University Medical Center Rotterdam (Pulmonary Medicine)
Funding Agreements
HEMISPHERX BIOPHARMA INC
Biotechnology
2023
Therapeutic Development Award Agreement between Cystic Fibrosis Foundation and Arrevus Inc. (December 13, 2021)
Funding Agreements
IDERA PHARMACEUTICALS, INC.
Biotechnology
DE
2022
Master Agreement for Operational and Technology Funding between NanoSynex Ltd. and Qualigen Therapeutics Inc.
Funding Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
2022
Payroll Support Program 3 Agreement between U.S. Department of the Treasury and Air Wisconsin Airlines LLC
Funding Agreements
HARBOR DIVERSIFIED, INC.
Biotechnology
NY
2022
Amended and Restated Revenue Sharing Agreement between Nuvalent, Inc. and Deerfield Healthcare Innovations Fund, L.P. and Deerfield Private Design Fund, IV, L.P.
Funding Agreements
Nuvalent, Inc.
Biotechnology
DE
2021
Funding Agreement between Cerevel Therapeutics, Inc. and BC Pinnacle Holdings, LP dated April 12, 2021
Funding Agreements
ARYA Sciences Acquisition Corp II
Biotechnology
NY
2021
Funding Agreement between Cerevel Therapeutics, Inc. and NovaQuest Co-Investment Fund XVI, L.P. dated April 12, 2021
Funding Agreements
ARYA Sciences Acquisition Corp II
Biotechnology
NY
2021
COVID-19 Outbreak Response Agreement between Variation Biotechnologies Inc. and CEPI
Funding Agreements
VBI Vaccines Inc
Biotechnology
2021
Research Grant Agreement between Kiromic BioPharma, Inc. and University of Texas MD Anderson Cancer Center for Pancreatic Cancer Biomarker Validation
Funding Agreements
Kiromic Biopharma, Inc.
Biotechnology
2021
Payroll Support Program Extension Agreement between U.S. Department of the Treasury and Air Wisconsin Airlines LLC
Funding Agreements
HARBOR DIVERSIFIED, INC.
Biotechnology
NY
2021
Capital Provision Agreement between PDL BioPharma, Inc. and EPPS Investments LLC dated December 11, 2020
Funding Agreements
PDL BIOPHARMA, INC.
Biotechnology
DE
2021
Therapeutic Development Award Agreement between Cystic Fibrosis Foundation and Matinas BioPharma Nanotechnologies, Inc.
Funding Agreements
Matinas BioPharma Holdings, Inc.
Biotechnology
NY
2021
BARDA–ContraFect Corporation Cost-Share Contract for Exebacase (CF-301) Development
Funding Agreements
CONTRAFECT Corp
Biotechnology
2021
Amendment No. 1 to Outbreak Response Funding Agreement (Step 2) between Novavax, Inc. and CEPI
Funding Agreements
NOVAVAX INC
Biotechnology
2021
Strategic Innovation Fund Agreement between Her Majesty the Queen in Right of Canada and Edesa Biotech Research, Inc.
Funding Agreements
Stellar Biotechnologies, Inc.
Biotechnology
2021
NIH Grant Award Notice to University of Maryland Baltimore for Phase IIb Clinical Trial on Hypoplastic Left Heart Syndrome
Funding Agreements
LONGEVERON LLC
Biotechnology
2021
NIH Grant Award Agreement Between National Institutes of Health and Longeveron LLC (June 24, 2020)
Funding Agreements
LONGEVERON LLC
Biotechnology
2021
NIH Grant Award Agreement for Phase 2b Clinical Trial Between National Institutes of Health and Longeveron LLC (April 26, 2019)
Funding Agreements
LONGEVERON LLC
Biotechnology
2021
Alzheimer’s Association Grant Agreement with Longeveron LLC for Clinical Evaluation of Stem Cells (April 1, 2019)
Funding Agreements
LONGEVERON LLC
Biotechnology
2021
Grant Agreement between Maryland Stem Cell Research Commission (via TEDCO) and Longeveron LLC (October 1, 2020)
Funding Agreements
LONGEVERON LLC
Biotechnology
DE
2021